Zentalis Pharmaceuticals (ZNTL) Long-Term Investments (2022 - 2024)
Historic Long-Term Investments for Zentalis Pharmaceuticals (ZNTL) over the last 3 years, with Q3 2024 value amounting to $349.9 million.
- Zentalis Pharmaceuticals' Long-Term Investments changed N/A to $349.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $349.9 million, marking a year-over-year change of. This contributed to the annual value of $454.9 million for FY2023, which is 204435.02% up from last year.
- Latest data reveals that Zentalis Pharmaceuticals reported Long-Term Investments of $349.9 million as of Q3 2024.
- In the past 5 years, Zentalis Pharmaceuticals' Long-Term Investments ranged from a high of $454.9 million in Q4 2023 and a low of $18.9 million during Q1 2023
- In the last 3 years, Zentalis Pharmaceuticals' Long-Term Investments had a median value of $35.7 million in 2022 and averaged $197.8 million.
- As far as peak fluctuations go, Zentalis Pharmaceuticals' Long-Term Investments plummeted by 4711.56% in 2023, and later soared by 228781.15% in 2024.
- Quarter analysis of 3 years shows Zentalis Pharmaceuticals' Long-Term Investments stood at $21.2 million in 2022, then soared by 2044.35% to $454.9 million in 2023, then decreased by 23.07% to $349.9 million in 2024.
- Its Long-Term Investments stands at $349.9 million for Q3 2024, versus $389.4 million for Q2 2024 and $451.4 million for Q1 2024.